Biography and Research Information
OverviewAI-generated summary
Barrett J. Burger's research has focused on critical care medicine, particularly investigating the effects of medications on patient outcomes. Recent publications examine the association between tocilizumab use and an increased risk of fungal infections in critically ill patients with COVID-19 and acute renal failure. Burger also studies patient preparedness for medical procedures, with work investigating pre-procedural anxiety and literacy prior to flexible bronchoscopy. Additional research has explored pleuropulmonary conditions, including spontaneous pneumothorax and blastoma presenting as tension pneumothorax. Burger has a recent publication record and has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Nikhil Meena, William T. Atchley, Rajani Jagana, and Sarenthia M. Epps.
Metrics
- h-index: 3
- Publications: 8
- Citations: 53
Selected Publications
-
Spontaneous pneumothorax or no pneumothorax at all? (2023)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
Pleuropulmonary Blastoma Presenting as Tension Pneumothorax (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
-
Learning from Each Other: A Multisite Collaborative to Reduce Electrolyte Testing (2020)
-
POPCoRN One-Pagers: Educational Materials for Pediatric Providers Caring for Adults (2020)
-
Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction (2017)
Collaboration Network
Top Collaborators
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
Similar Researchers
Based on overlapping research topics